People: Ligand Pharmaceuticals Inc (LGND.O)

LGND.O on Consolidated Issue listed on NASDAQ Global Market

52.04USD
29 Aug 2014
Price Change (% chg)

$0.08 (+0.15%)
Prev Close
$51.96
Open
$51.96
Day's High
$52.17
Day's Low
$51.28
Volume
139,717
Avg. Vol
394,130
52-wk High
$80.42
52-wk Low
$39.75

Search Stocks

Berkman, Charles 

Brief Biography

Mr. Charles S. Berkman J.D., serves as Vice President, General Counsel, Secretary of Ligand Pharmaceuticals Inc., since April 2007. Mr. Berkman joined the Company in November 2001 and previously served as Associate General Counsel and Chief Patent Counsel for the Company (and Secretary since March 2007). Prior to joining the Company, Mr. Berkman was an attorney at the international law firm of Baker & McKenzie from November 2000 to November 2001. Before that he served as an attorney at the law firm of Lyon & Lyon from 1993 to November 2000, where he specialized in intellectual property law. Mr. Berkman earned a BS in chemistry from the University of Texas and a JD from the University of Texas School of Law.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
396,691 -- 280,270 731,761

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 56,198 1,742,700.00
Name Fiscal Year Total

John Kozarich

--

John Higgins

3,004,910

Nishan de Silva

1,125,130

Matthew Foehr

1,965,460

Charles Berkman

731,761

Jason Aryeh

--
As Of 30 Dec 2013
Search Stocks